Morning Market Gainers
DealerTrack Technologies Inc (NASDAQ: TRAK) shares surged 57.67 percent to $62.83 after the company agreed to be acquired for $4 billion, or $63.25 per share by Cox Automotive in an all-cash transaction.
RedHill Biopharma Ltd – ADR (NASDAQ: RDHL) gained 32.20 percent to $21.76 after the company reported that its RHB-105 Phase 3 study met its primary endpoint.
Ruthigen Inc (NASDAQ: RTGN) jumped 23.93 percent to $5.04. Ruthigen and Pulmatrix stockholders approved the merger between Ruthigen and Pulmatrix.
Trivascular Technologies Inc (NASDAQ: TRIV) shares rose 10.27 percent to $7.62 after the company reported the FDA approval of Ovation iX(TM) Iliac Stent Graft.
Neurometrix Inc (NASDAQ: NURO) shares climbed 9.57 percent to $1.03 as the company launched wearable pain relief technology.
Idera Pharmaceuticals Inc (NASDAQ: IDRA) shares surged 4.20 percent to $3.72. JP Morgan initiated coverage on Idera Pharmaceuticals with a Overweight rating.
bluebird bio Inc (NASDAQ: BLUE) shares surged 1.42 percent to $183.38 after the company reported new data from HGB-205 study. Philip Gregory, D. Phil., joined bluebird bio as Chief Scientific Officer. JP Morgan maintained bluebird bio with a Overweight and raised the price target from $200.00 to $244.00.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.